NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...
NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...
Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...
Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public offering. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback